Overexpression of MYC, with knockdown of PTEN, TP53 with or without AR expression (MPPA or MPP) are able to transform organoids in vitro and these transformed organoids can form prostate cancer in vivo as determined by histology and expression of the clinical marker AMACR with lack of basal cells. The gene discussed is PTEN; the disease is prostate carcinoma.